CD8A and gastrointestinal stromal tumor: Third, Tieniber et al. demonstrated that imatinib reduced the infiltration of effector CD8+ T cells and increased that of naive T cells (Tn) in GIST, which were accompanied by alterations of chemokines secretion, CD8+ T cells recruitment and PI3K signaling within CD8+ T cells [196].